ArticleCell communication and signaling : CCS2026
Genotype-environment interaction drives the onset of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency in carriers of single heterozygous ETFDH variants.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundRiboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (RR-MADD) is an autosomal recessive disorder of fatty acid oxidation predominantly caused by variants in the ETFDH gene. However, approximately 10% of patients carry a single heterozygous variant. We hypothesize that ETFDH haploinsufficiency may contribute to the development of RR-MADD, especially under certain environmental stressors.
methodsSkin fibroblasts derived from one RR-MADD patient carrying a heterozygous variant in ETFDH and his asymptomatic father carrying the same variant were cultured. Under varying concentrations of riboflavin, ETFDH gene expression profiles, intracellular free fatty acid (FFA) levels, mitochondrial function, cellular viability, and accumulation of reactive oxygen species (ROS) and lipid droplets were assessed and compared between the two cell lines. These phenotypic comparisons were subsequently extended to HEK293 cell models engineered to carry either heterozygous or homozygous c.917G > A variants in ETFDH. Etfdh knock-in mice carrying c.250G > A (p.A84T) variants were used to evaluate the contribution of single heterozygous variants to disease susceptibility at the organismal level.
resultsUnder identical culture conditions, fibroblasts from the RR-MADD patient and his father exhibited comparable levels of ETFDH gene expression and FFA, along with similar mitochondrial function, cellular viability, ROS production, and accumulation of lipid droplets. This finding suggests that environmental factors rather than genotype cause phenotypic differences between the two individuals. Moreover, exposure to severe riboflavin deficiency induced a similar RR-MADD phenotype in HEK293 cells regardless of whether they carried heterozygous or homozygous variants. Mice harboring the heterozygous Etfdh c.250G > A variant exhibited a classic RR-MADD phenotype and pathological changes following combined dietary interventions consisting of riboflavin deficiency and high-fat diet.
conclusionsThis study demonstrates that single heterozygous ETFDH variants confer increased susceptibility to RR-MADD in the presence of specific environmental stressors, offering new genetic insights into the inheritance pattern of the disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.